Delivery Order SPE2DB22D9367-SPE2DB24FSV54

Award Date 12/27/23
Potential Completion Date 1/19/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML SYRINGE 0.05ML. The $128,953.90 contract has a completion date of January 19, 2024. This delivery order is part of a larger indefinite delivery contract with DMS Pharmaceutical Group to supply various pharmaceutical and medical products to military treatment facilities globally. The contract does not have a set-aside...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA (aflibercept) 2 mg/0.05 ml vials. The $188,097.70 delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with DLA Troop Support Medical to supply a wide range of pharmaceutical and medical products to military treatment facilities worldwide. This contract vehicle has a potential value...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Eylea 2 mg/0.05 ml vial. The contract has a completion date of October 4, 2022 and a potential value of $135,794.00. This delivery order is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA Troop Support Medical to provide a variety of pharmaceutical and medical supplies to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $5,253.92, has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to support military treatment facilities worldwide through various DLA contracts and indefinite...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EYLEA 2 MG/0.05 ML SYRINGE 0.05ML pharmaceutical products. This award, valued at $120,714.60, has a completion date of April 17, 2023. DMS Pharmaceutical Group holds various federal contracts and indefinite delivery vehicles (IDVs) to provide a range of pharmaceutical and medical supplies to support military treatment facilities...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $134,355.50, was issued against an existing indefinite delivery contract between DMS Pharmaceutical Group and DLA to supply various medical supplies and pharmaceutical products to support military treatment facilities globally. The delivery order has a...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,338.24, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML to the DLA. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $135,794.00, is issued against an existing indefinite-delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical supplies to military treatment facilities worldwide. The contract does not have a set-aside designation. DMS Pharmaceutical Group is a leading...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order (SPE2DX15D9114|SPE2DX25F5ZHY) valued at $25,838.60 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML syringes. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) under the SPE2DB program, which enables the DLA to issue firm fixed-price orders for a wide range of pharmaceutical products to support the medical supply needs of military...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The order, valued at $38,757.90, is for the provision of EYLEA 2 MG/0.05 ML SYRINGE 0.05ML, with a completion date of March 1, 2024. The order is placed against a larger indefinite delivery contract, contract 4600082013 under the DLA's SPE2DB program, valued at up to $4,999,999 through the end...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSV54
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML syringes with a potential value of $20,050.65. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to supply pharmaceuticals and medical products to military treatment facilities worldwide. The contract does not have a set-aside designation, and the delivery order is expected to be completed by January 19, 2024.

Generated 3/27/24, 10:39 AM